Evidence map›Paper›PMID 21606248›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondii.

Jonathan S Silver, Jason S Stumhofer, Sara Passos, Matthias Ernst, Christopher A Hunter

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. The Modulated Role ofPathogens (Basel, Switzerland) · 2023
    Article
  5. Animal venoms: a novel source of anti-Frontiers in pharmacology · 2023
    Review
  6. Effects of Ovine Monocyte-Derived Macrophage Infection by Recently IsolatedAnimals : an open access journal from MDPI · 2022
    Article
  7. Article
  8. Article
  9. Inhibitory Effects ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jonathan S SilverDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Jason S Stumhofer
Sara Passos
Matthias Ernst
Christopher A Hunter
University of Pennsylvania · USLudwig Cancer Research · AU

Funding

PARASITOLOGY: MODERN APPROACHEST32AI007532 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HERBERT, DE'BROSKI R · 1998 to 2022
$5.0M
Regulation of the early immune response to toxoplasma gondiiR01AI042334 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HUNTER, CHRISTOPHER A · 1998 to 2013
$4.1M
Role of dendritic cells in resistance to Toxoplasma.R01AI071302 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HUNTER, CHRISTOPHER A · 2006 to 2010
$2.4M
NIAID NIH HHS AI 084882NIAID NIH HHS AI42334NIAID NIH HHS R01 AI042334NIAID NIH HHS R01 AI071302NIAID NIH HHS T32 AI007532NIAID NIH HHS T32 AI007532
6 · The paper itself

Abstract

IL-6 and IL-27 are closely related cytokines that play critical but distinct roles during infection with Toxoplasma gondii. Thus, IL-6 is required for the development of protective immunity to this pathogen, whereas IL-27 is required to limit infection-induced pathology. Paradoxically, these factors both signal through gp130, but little is known about how the signals downstream of gp130 are integrated to coordinate the immune response to infection. To better understand these events, gp130 Y757F mice that have a mutation in gp130 at the binding site for suppressor of cytokine signaling 3, a critical negative regulator of gp130 signaling, were infected with T. gondii. These mutant mice were acutely susceptible to this challenge, characterized by an early defect in the production of IL-12 and IFN-γ and increased parasite burdens. Consistent with the reduced IL-12 levels, IL-6, but not other gp130 cytokines, was a potent antagonist of IL-12 production by gp130 Y757F macrophages and dendritic cells in vitro. Moreover, in gp130 Y757F mice, blocking IL-6 in vivo, or administration of rIL-12, during infection restored IFN-γ production and protective immunity. Collectively, these studies highlight that a failure to abbreviate IL-6-mediated gp130 signaling results in a profound anti-inflammatory signal that blocks the generation of protective immunity to T. gondii.

Indexed as

AnimalsCells, CulturedCytokine Receptor gp130Genetic Predisposition to DiseaseImmunity, InnateInflammation MediatorsInterleukin-6Interleukin-6 InhibitorsMiceMice, 129 StrainMice, Inbred C57BLMice, Inbred CBAMice, KnockoutSignal TransductionToxoplasmaToxoplasmosisCytokine Receptor gp130Inflammation MediatorsInterleukin-6Interleukin-6 Inhibitors

Identifiers

PMID21606248
PMCPMC3119722
OpenAlexW1862103585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.